Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases
Michał Wiciński, Karol Górski, Maciej Walczak, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 4052-4052
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
R. Manjula, Kumari Anuja, Francisco J. Alcaı́n
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 141
A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research
Mukesh Nandave, Rituparna Acharjee, Kinkini Bhaduri, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124581-124581
Closed Access | Times Cited: 38
Coronaviruses and the central nervous system
Susan Morgello
Journal of NeuroVirology (2020) Vol. 26, Iss. 4, pp. 459-473
Open Access | Times Cited: 62
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
Federica Ferrari, Antonio Moretti, R. F. Villa
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108277-108277
Closed Access | Times Cited: 32
Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy
Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1065-1065
Open Access | Times Cited: 15
Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling
Hany H. Arab, Ahmed H. Eid, Ayman M. Mahmoud, et al.
Life Sciences (2021) Vol. 273, pp. 119295-119295
Closed Access | Times Cited: 30
The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment
Iwona Piątkowska‐Chmiel, Monika Gawrońska‐Grzywacz, Łukasz Popiołek, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases
Xiaopeng Hu, Xisheng Wang, Xingkui Xue
Molecules (2022) Vol. 27, Iss. 14, pp. 4498-4498
Open Access | Times Cited: 20
Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches
Akhtar Atiya, Debarati Das Gupta, Abdulrhman Alsayari, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6423-6430
Open Access | Times Cited: 12
Mechanistic study of gold nanoparticles of Vildagliptin and Vitamin E in diabetic cognitive impairment
Sweta Priyadarshini Pradhan, P. Tejaswani, Nishigandha Sa, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104508-104508
Closed Access | Times Cited: 12
Integrating micellar HPLC and green analytical chemistry tools in greenness assessment of five commonly Co-formulated antidiabetic drugs
Adel Ehab Ibrahim, Khaled Maged, Magda Elhenawee, et al.
Sustainable Chemistry and Pharmacy (2023) Vol. 35, pp. 101199-101199
Closed Access | Times Cited: 11
Research progress of small-molecule natural medicines for the treatment of ischemic stroke
Kui Liu, Ling Wang, Tao Pang
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 21-30
Closed Access
Gastroprotective Effect of Linagliptin on Indomethacin-Induced Gastric Ulceration in Mice: Crosstalk Between Oxidative Stress and Inflammasome Pathways
Maha E. Wally, Mohamed H. Aly
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 808-818
Closed Access
Optimization of Linagliptin-Loaded Polymersomes via Response Surface Methodology: A Repurposed Therapeutic Strategy for Hepatic Encephalopathy Prevention
Nabila M. Sweed, Heba T. Elbalkiny, Eslam Magdy, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106855-106855
Closed Access
From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1
Martin Law, Peichun Wang, Zhong-Yan Zhou, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1495-1495
Open Access | Times Cited: 3
Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
Fen Cao, Kun Wu, Yongzhi Zhu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 18
Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease
Yuka Ikeda, Nozomi Nagase, Ai Tsuji, et al.
World Journal of Biological Chemistry (2021) Vol. 12, Iss. 6, pp. 104-113
Open Access | Times Cited: 17
Linagliptin counteracts rotenone’s toxicity in non-diabetic rat model of Parkinson’s disease: Insights into the neuroprotective roles of DJ-1, SIRT-1/Nrf-2 and implications of HIF1-α
Rania Z ElGamal, Mariane G. Tadros, Esther T. Menze
European Journal of Pharmacology (2023) Vol. 941, pp. 175498-175498
Closed Access | Times Cited: 5
Exploring the molecular mechanism of linagliptin in osteosarcoma cell lines for anti-cancer activity
Asiye Gök Yurttaş, Mustafa Fatih Daşcı
Pathology - Research and Practice (2023) Vol. 248, pp. 154640-154640
Closed Access | Times Cited: 5
COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies
Ya Yang, Yalei Zhao, Fen Zhang, et al.
Aging and Disease (2020) Vol. 11, Iss. 6, pp. 1481-1481
Open Access | Times Cited: 14
Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis
Denis Delić, Thomas Klein, Christian T. Wohnhaas, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117778-117778
Open Access | Times Cited: 1
Ultrastructural studies of the neurovascular unit reveal enhanced endothelial transcytosis in hyperglycemia‐enhanced hemorrhagic transformation after stroke
Xiaomin Xu, Liuqi Zhu, Ke Xue, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 1, pp. 123-133
Open Access | Times Cited: 10
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease
Gurpreet Singh, T. Pushpa, Sunil Gupta, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 10, pp. 1429-1438
Closed Access | Times Cited: 4
Vitamin K alleviates bone calcium loss caused by Salmonella Enteritidis through carboxylation of osteocalcin
Yaojun Liu, R. Mosenthin, Lihong Zhao, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 5
The Potential for Multi-Disease Treatment: Applications of Dipeptidyl Peptidase Inhibitors
甜甜 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 07, pp. 1469-1477
Closed Access
Page 1 - Next Page

Scroll to top